PURPOSE: Vigorous physical activity after diagnosis of localized prostate cancer may reduce the risk of disease progression and prostate cancer-specific mortality. The molecular mechanisms by which physical activity may exert protective effects in the prostate remain unknown. METHODS: We examined the associations between self-reported physical activity and gene expression patterns in morphologically normal prostate tissue of 71 men with low-risk prostate cancer on active surveillance. Differential gene expression, gene set, and pathway analyses were conducted comparing dichotomous groups defined by type, intensity, and amount of physical activity reported. RESULTS: Cell cycling and DNA repair pathways were up-regulated in men who participated in ≥ 3 h/week vigorous activity compared with men who did not. In addition, canonical pathways involved in cell signaling and metabolism, the cellular effects of sildenafil (Viagra), and the Nrf2-mediated oxidative stress response were modulated in men who reported ≥ 3 h/week of vigorous activity. Differential expression analysis at the individual gene level revealed modest differences between men who performed vigorous activity for ≥ 3 h/week and those who did not. There were no differences in prostate gene expression in comparisons with exercise groupings that did not consider both duration and intensity of activity. CONCLUSIONS: Prostate gene expression and pathway analyses revealed sets of transcripts that may be modulated in normal prostate tissue by participating in ≥ 3 h/week of vigorous activity after diagnosis of low-risk prostate cancer. These findings suggest potential biological mechanisms by which vigorous activity may reduce risk of prostate cancer progression and warrant further study and validation.
PURPOSE: Vigorous physical activity after diagnosis of localized prostate cancer may reduce the risk of disease progression and prostate cancer-specific mortality. The molecular mechanisms by which physical activity may exert protective effects in the prostate remain unknown. METHODS: We examined the associations between self-reported physical activity and gene expression patterns in morphologically normal prostate tissue of 71 men with low-risk prostate cancer on active surveillance. Differential gene expression, gene set, and pathway analyses were conducted comparing dichotomous groups defined by type, intensity, and amount of physical activity reported. RESULTS: Cell cycling and DNA repair pathways were up-regulated in men who participated in ≥ 3 h/week vigorous activity compared with men who did not. In addition, canonical pathways involved in cell signaling and metabolism, the cellular effects of sildenafil (Viagra), and the Nrf2-mediated oxidative stress response were modulated in men who reported ≥ 3 h/week of vigorous activity. Differential expression analysis at the individual gene level revealed modest differences between men who performed vigorous activity for ≥ 3 h/week and those who did not. There were no differences in prostate gene expression in comparisons with exercise groupings that did not consider both duration and intensity of activity. CONCLUSIONS: Prostate gene expression and pathway analyses revealed sets of transcripts that may be modulated in normal prostate tissue by participating in ≥ 3 h/week of vigorous activity after diagnosis of low-risk prostate cancer. These findings suggest potential biological mechanisms by which vigorous activity may reduce risk of prostate cancer progression and warrant further study and validation.
Authors: Maximilian Diehn; Gavin Sherlock; Gail Binkley; Heng Jin; John C Matese; Tina Hernandez-Boussard; Christian A Rees; J Michael Cherry; David Botstein; Patrick O Brown; Ash A Alizadeh Journal: Nucleic Acids Res Date: 2003-01-01 Impact factor: 16.971
Authors: Lu Tian; Steven A Greenberg; Sek Won Kong; Josiah Altschuler; Isaac S Kohane; Peter J Park Journal: Proc Natl Acad Sci U S A Date: 2005-09-08 Impact factor: 11.205
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Marc A Dall'Era; Matthew R Cooperberg; June M Chan; Benjamin J Davies; Peter C Albertsen; Laurence H Klotz; Christopher A Warlick; Lars Holmberg; Donald E Bailey; Meredith E Wallace; Philip W Kantoff; Peter R Carroll Journal: Cancer Date: 2008-04-15 Impact factor: 6.860
Authors: Dean Ornish; Mark Jesus M Magbanua; Gerdi Weidner; Vivian Weinberg; Colleen Kemp; Christopher Green; Michael D Mattie; Ruth Marlin; Jeff Simko; Katsuto Shinohara; Christopher M Haqq; Peter R Carroll Journal: Proc Natl Acad Sci U S A Date: 2008-06-16 Impact factor: 11.205
Authors: June M Chan; Vivian Weinberg; Mark J Magbanua; Eduardo Sosa; Jeffry Simko; Katsuto Shinohara; Scot Federman; Mike Mattie; Millie Hughes-Fulford; Christopher Haqq; Peter R Carroll Journal: Cancer Causes Control Date: 2010-11-20 Impact factor: 2.506
Authors: Irina Dinu; John D Potter; Thomas Mueller; Qi Liu; Adeniyi J Adewale; Gian S Jhangri; Gunilla Einecke; Konrad S Famulski; Philip Halloran; Yutaka Yasui Journal: BMC Bioinformatics Date: 2007-07-05 Impact factor: 3.169
Authors: James Y Dai; Bo Wang; Xiaoyu Wang; Anqi Cheng; Suzanne Kolb; Janet L Stanford; Jonathan L Wright Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-11-21 Impact factor: 4.254
Authors: Daniel A Galvão; Dennis R Taaffe; Nigel Spry; Robert A Gardiner; Renea Taylor; Gail P Risbridger; Mark Frydenberg; Michelle Hill; Suzanne K Chambers; Phillip Stricker; Tom Shannon; Dickon Hayne; Eva Zopf; Robert U Newton Journal: Nat Rev Urol Date: 2016-03-08 Impact factor: 14.432
Authors: Ericka M Ebot; Lorelei A Mucci; Claire H Pernar; Giovanni Parmigiani; Edward L Giovannucci; Eric B Rimm; Svitlana Tyekucheva; Massimo Loda; Stephen P Finn; Matthew G Vander Heiden; Michelangelo Fiorentino Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-01-26 Impact factor: 4.254